Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.

Eiseman, J L

Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. [electronic resource] - Cancer research Nov 1998 - 4864-70 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0008-5472


Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Aziridines--pharmacology
Humans
Male
Mice
Mice, SCID
Prostatic Neoplasms--drug therapy
Radiation-Sensitizing Agents--pharmacology
Spermine--analogs & derivatives
Tumor Cells, Cultured